Recursion Pharmaceuticals formed in 2013, co-founded by Gibson. Three years later, the young company raised its Series A round of funding.

Recursion is hosting about 60 investors and analysts at its headquarters in Utah. It has generated tons of data with AI and robots, aiming to find a better way to make drugs.